Editas Expands CRISPR Capabilities through New Technology Licensing – Genetic Engineering & Biotechnology News
Boston Business Journal |
Editas Expands CRISPR Capabilities through New Technology Licensing
Genetic Engineering & Biotechnology News Officials at Editas Medicine say they exclusively licensed intellectual property related to new CRISPR technologies for human therapeutics. These global licensing agreements include intellectual property owned by the Broad Institute of MIT and Harvard … A better approach to gene editing? Editas snags new exclusive license from BroadBoston Business Journal Editas Medicine Inks Licensing Deals for CRISPR IPGenomeWeb As Its Rivals Team Up, Editas Buys Next-Gen CRISPR From Old FriendsXconomy BioPharma Dive –JD Supra (press release) –Genetic Literacy Project all 13 news articles » |
FiercePharma |
Matt Kapusta named CEO of gene therapy pioneer UniQure
FiercePharma Hoping to gain some stability, Dutch gene therapy company UniQure has awarded the CEO role to Matthew Kapusta, who took over as interim leader in September, and who now becomes the company’s third CEO in a year. The company, which developed … |
HealthNewsReview.org |
Searching for the source of stem cell “fountain of youth” stories
HealthNewsReview.org A new study made global headlines last week with the claim that researchers can now “reverse” aging in mice. The study authors used a technique called “cellular reprogramming,” which is used to transform regular adult cells into pluripotent stem cells, … |
|
Israel’s BrainStorm to begin advanced trial for ALS stem cell treatment
Reuters This pathway usually involves a custom-made product, such as NurOwn, which is made using a patient’s own cells. “We foresee possible treatments under this pathway as early as the second half of 2017,” Lebovits said. According to the ALS Association, … |
Globalnews.ca |
Manitoba family searching for stem cell match for baby with leukemia
CTV News A Manitoba family has begun a desperate search across Canada for a stem cell donor for their baby boy, who has a type of leukemia unresponsive to chemotherapy. The match is particularly difficult to find because 13-month-old Tegveer Minhas has an … Manitoba family desperately asking strangers to help save their son’s lifeGlobalnews.ca |